Status:
COMPLETED
Lidocaine on Manifestations of Fibromyalgia
Lead Sponsor:
Federal University of São Paulo
Conditions:
Fibromyalgia
Chronic Pain
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
Background and Objectives: Fibromyalgia is a pain syndrome characterized by numerous manifestations. The objective of this study was to evaluate the effect of the combination of intravenous lidocaine ...
Detailed Description
Amitriptyline was chosen in the present study because it is the most widely used antidepressant with proven analgesic efficacy for the treatment of a variety of chronic pain syndromes. Amitriptyline a...
Eligibility Criteria
Inclusion
- pain in the four quadrants of the body for at least 3 months
- sleep disorders
- fatigue
- subjective edema
- depression
- paresthesia.
Exclusion
- alterations in thyroid
- rheumatological
- renal and hepatic function
- trauma
- rheumatic, neuromuscular or psychiatric disease
- infectious arthropathy
- other pain syndromes
- drug hypersensitivity
- pregnancy
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00991848
Start Date
January 1 2005
End Date
September 1 2008
Last Update
October 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of São Paulo
São Paulo, São Paulo, Brazil